Scott's Hip Heals, but Mets' Rotation Puzzle Lingers

Christian Scott threw without incident in Sunday's bullpen session, positioning the Mets righty to rejoin the roster as early as next Saturday when he becomes first eligible off the 15-day IL. The hip impingement that sidelined him appears to have resolved cleanly—a rare piece of good news for a franchise that has cycled through four-plus rotation options in the span of two months.

But Scott's return masks deeper instability. When he went down, the Mets were already operating with Kodai Senga out and Clay Holmes unavailable, leaving Nolan McLean and Freddy Peralta as the only consistent depth pieces. Tobias Myers got a trial run in Scott's spot and promptly imploded against Cincinnati, surrendering seven earned runs and failing to escape the second inning—a reminder that organizational depth is not the same as organizational competence. David Peterson has been shuffled between bullpen and starter roles depending on the week's crisis. Sean Manaea is now in the rotation mix. The instability is palpable.

Scott himself presents a complicated profile. Since his April return from Tommy John surgery, he's posted a 3.10 ERA over nine starts with encouraging velocity gains and a sweeper that whiffs at 32.9%—a legitimate plus pitch. But a 26.4% strikeout rate coupled with a double-digit walk rate suggests command volatility that could resurface under stress. His cutter, deployed 17% of the time this season (compared to near-zero volume in 2024), has generated positive Run Value, indicating the post-surgery toolkit is legitimately sharper than the pre-injury version. Still, elite fourth-starter production is the ceiling; ace-level depth remains out of reach.

For bettors, Scott's return carries minimal immediate equity. The Mets' next-weekend matchups (likely against division competition) should feature reliable rotation spots occupied by established arms or recent performers. Scott stepping into the fourth or fifth starter slot doesn't materially shift team total expectations, and his individual strikeout prop—if offered at opening—will reflect his mediocre K-rate despite the improved stuff. The real opportunity lies in fade territory: resist overs on Mets team totals predicated on rotation health or stability. The organization is still two arms short, and Scott's return addresses symptom management, not the underlying shortage. Wait until Senga or Holmes actually pitch games, not just rehab assignments, before treating New York's staff as whole again.